NORTHWEST BIOTHERAPEUTICS IN's ticker is NWBO and the CUSIP is 66737P600. A total of 12 filers reported holding NORTHWEST BIOTHERAPEUTICS IN in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $5,492 | -99.9% | 7,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $4,998,000 | +13.3% | 7,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $4,410,000 | -36.7% | 7,000 | -30.0% | 0.00% | 0.0% |
| Q1 2022 | $6,970,000 | -0.4% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $7,000,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Moloney Securities Asset Management, LLC | 352,660 | $320,815 | 0.06% |
| Opus Capital Group, LLC | 60,150 | $55 | 0.01% |
| AlphaMark Advisors, LLC | 14,007 | $13 | 0.01% |
| ADVISORS MANAGEMENT GROUP INC /ADV | 10,270 | $9 | 0.00% |
| LEE DANNER & BASS INC | 20,000 | $18 | 0.00% |
| Williams Jones Wealth Management, LLC. | 44,000 | $40,027 | 0.00% |
| MAI Capital Management | 20,000 | $18,194 | 0.00% |
| Bartlett & Co. LLC | 4,292 | $4 | 0.00% |
| Coston, McIsaac & Partners | 1,000 | $0 | 0.00% |